1. Home
  2. ACGL vs RMD Comparison

ACGL vs RMD Comparison

Compare ACGL & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACGL
  • RMD
  • Stock Information
  • Founded
  • ACGL 2001
  • RMD 1989
  • Country
  • ACGL Bermuda
  • RMD United States
  • Employees
  • ACGL N/A
  • RMD N/A
  • Industry
  • ACGL Property-Casualty Insurers
  • RMD Medical/Dental Instruments
  • Sector
  • ACGL Finance
  • RMD Health Care
  • Exchange
  • ACGL Nasdaq
  • RMD Nasdaq
  • Market Cap
  • ACGL 35.1B
  • RMD 35.7B
  • IPO Year
  • ACGL 1995
  • RMD 1995
  • Fundamental
  • Price
  • ACGL $88.13
  • RMD $231.60
  • Analyst Decision
  • ACGL Buy
  • RMD Buy
  • Analyst Count
  • ACGL 16
  • RMD 12
  • Target Price
  • ACGL $117.19
  • RMD $250.67
  • AVG Volume (30 Days)
  • ACGL 1.9M
  • RMD 1.1M
  • Earning Date
  • ACGL 02-10-2025
  • RMD 01-30-2025
  • Dividend Yield
  • ACGL 5.67%
  • RMD 0.92%
  • EPS Growth
  • ACGL N/A
  • RMD 40.24
  • EPS
  • ACGL 11.19
  • RMD 8.47
  • Revenue
  • ACGL $17,440,000,000.00
  • RMD $4,926,773,000.00
  • Revenue This Year
  • ACGL N/A
  • RMD $10.03
  • Revenue Next Year
  • ACGL $6.65
  • RMD $7.37
  • P/E Ratio
  • ACGL $7.88
  • RMD $27.35
  • Revenue Growth
  • ACGL 27.92
  • RMD 9.38
  • 52 Week Low
  • ACGL $85.79
  • RMD $170.56
  • 52 Week High
  • ACGL $116.47
  • RMD $263.05
  • Technical
  • Relative Strength Index (RSI)
  • ACGL 37.78
  • RMD 42.13
  • Support Level
  • ACGL $87.78
  • RMD $228.87
  • Resistance Level
  • ACGL $89.35
  • RMD $240.00
  • Average True Range (ATR)
  • ACGL 1.68
  • RMD 5.47
  • MACD
  • ACGL -0.38
  • RMD -1.18
  • Stochastic Oscillator
  • ACGL 10.32
  • RMD 15.95

About ACGL Arch Capital Group Ltd.

Arch Capital Group Ltd is a Bermuda company which writes insurance and reinsurance with operations in Bermuda, the United States, Canada, Europe, Australia and United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage two operating segments: corporate and other. The insurance segment provides specialty risk solutions to client across a variety of industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: